Showing results (51-60 of 517) with videos related to
Sort By:
Pageof 52
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 19, 2007
Circumferential and axial distribution of esophageal mucosal damage in reflux diseaseA Edebo, M Vieth, W Tam, et al.Digestive Diseases (Basel, Switzerland)|September 24, 2004
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?M Vieth, U Peitz, J Labenz, et al.Alimentary Pharmacology & Therapeutics|February 1, 2005
A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitisY Marakhouski, B Fixa, J Holomán, et al.Alimentary Pharmacology & Therapeutics|January 6, 2006
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusM Vieth, M Kulig, A Leodolter, et al.Alimentary Pharmacology & Therapeutics|June 19, 2008
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control studyK Monkemuller, H Neumann, M Nocon, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 14, 2008
Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's databaseB H A von Rahden, H J Stein, A Weber, et al.Journal of Healthcare Resource Management|November 3, 1996
Nurses' role in disease case managementC M StolteJournal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.Alimentary Pharmacology & Therapeutics|November 11, 2011
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD studyP Malfertheiner, M Nocon, M Vieth, et al.Pageof 52